Related references
Note: Only part of the references are listed.Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway
E. A. M. Bouwens et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study
Stephane Zuily et al.
THROMBOSIS RESEARCH (2013)
Development and application of an automated chromogenic thrombin generation assay that is sensitive to defects in the protein C pathway
Laura Green et al.
THROMBOSIS RESEARCH (2012)
Interactions of Human Monoclonal and Polyclonal Antiphospholipid Antibodies With Serine Proteases Involved in Hemostasis
Anastasia Lambrianides et al.
ARTHRITIS AND RHEUMATISM (2011)
Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy
A. Gatt et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Prediction of Recurrent Venous Thromboembolism by Endogenous Thrombin Potential and D-Dimer
Sabine Eichinger et al.
CLINICAL CHEMISTRY (2008)
High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study
M. Besser et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
The History of Phenotypic Testing in Thrombosis and Hemostasis
Armando Tripodi
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2008)
A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies
Guillermo Ruiz-Irastorza et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants
S. Liestol et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants
Sigurd Liestol et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation
Gregor Hron et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Acquired activated protein C resistance associated with IgG antibodies against β2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism
J Nojima et al.
CLINICAL CHEMISTRY (2005)
Phenotyping the haemostatic system by thrombography-potential for the estimation of thrombotic risk
W Regnault et al.
THROMBOSIS RESEARCH (2004)
High avidity anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome
S Cucnik et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Calibrated automated thrombin generation measurement in clotting plasma
HC Hemker et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2003)
The Calibrated Automated Thrombogram (CAT):: A universal routine test for hyper- and hypocoagulability
HC Hemker et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2002)
Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus
C Male et al.
BLOOD (2001)
Share Paper
